Riskpilot← Back to searchSign inGet full accessNaprapatcenter i Visby AB
ABActiveOrg 5565708111Cypressgatan 1 BPhysiotherapy activities · NACE 8695Est. 19993 employees
Revenue 2025
SEK 3,7M
+3% vs 2024
EBITDA margin
8.5%
-15% vs 2024
Equity ratio
87.8%
Financial strength
Net profit 2025
SEK 291K
+36% vs 2024
| Revenue | SEK 3,7M | +3% |
| EBITDA | SEK 312K | -15% |
| Net profit | SEK 291K | +36% |
| Total assets | SEK 1,2M | +9% |
| Equity | SEK 1,1M | +22% |
| Employees | 3 | — |
Legal name
Naprapatcenter i Visby AB
Org number
5565708111
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
19 maj 1999
Share capital
SEK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall driva naprapatbehandling, rehabträning och friskvård samt konsultation och försäljning av produkter inom friskvård och ergonomi samt med dessa verksamheter förenlig verksamhet. Bolaget ska även äga och förvalta fast egendom och värdepapper.
Address
Cypressgatan 1 B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 001 | 3 245 | 3 348 | 3 567 | 3 669 |
| Staff expenses | — | −1 960 | −2 088 | −2 139 | −2 260 |
| EBITDA | 296 | 306 | 295 | 366 | 312 |
| Depreciation & amort. | −0 | −11 | −22 | −22 | −22 |
| EBIT | 296 | 295 | 273 | 344 | 291 |
| Net financials | −6 | −39 | −5 | −1 | 1 |
| Profit before tax | 290 | 256 | 268 | 269 | 366 |
| Tax | −60 | −53 | −55 | −55 | −76 |
| Net profit | 230 | 203 | 213 | 214 | 291 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 930 | 993 | 1 012 | 1 116 | 1 219 |
| Equity | 650 | 653 | 765 | 879 | 1 070 |
| Long-term debt | 140 | 97 | 54 | 11 | 0 |
| Short-term debt | 140 | 244 | 193 | 151 | 149 |
| Total debt | 280 | 340 | 247 | 162 | 149 |
EBITDA margin
8.5%
This company
15.8%
Market median
-46% vs market
20212025
Equity ratio
87.8%
This company
38.2%
Market median
+130% vs market
20212025
Return on equity
27.2%
This company
18.4%
Market median
+48% vs market
20212025
Net profit margin
7.9%
This company
8.1%
Market median
-2% vs market
20212025
Asset turnover
3.01×
This company
1.12×
Market median
+169% vs market
20212025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Naprapatcenter i Visby AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Erik Garvén | Board of Directors | 0 companies |
| Ulla Kristina Garvén | Deputy Board Member | 0 companies |